Literature DB >> 25911817

[Determination of lignans in schisandrae sphenantherae fructus from different regions].

Jie Yang, Jin-Ao Duan, Guo-Long Li, Zhen-Hua Zhu, Tai-Lei Zhu, Da-Wei Qian, Zhi-Shu Tang.   

Abstract

With an objective to provide an experimental basis for scientific officinal of Schisandrae Sphenantherae Fructus, this research uses UPLC-TQ/MS method to analyze 7 different kinds of lignan in 70 batches of Schisandra sphenantherae Fructus samples from 9 regions. The results showed that in the area south of Qinling mountains, Schisandrae sphenantherae Fructus from Zhashui county and Shanyang county of Shangluo mainly contained schisantherin A and deoxyschizandrin. However, Schisandrae sphenantherae Fructus from Mei county of Baoji, Shiquan county and Ningshan county of Ankang, and Lueyang county of Hanzhong, mainly contained anwuligan. Samples from Ningshan county also consists relatively high level of deoxyschizandrin. In the central area of Qinling mountains and the Daba mountains, Schisandrae Sphenantherae Fructus from Nanzheng county of Hanzhong mainly contained schisanhenol and deoxyschizandrin. In conclusion, the kinds and level of lignan differ significantly in Schisandrae sphenantherae Fructus produced in different regions. In practical application, Schisandrae Sphenantherae Fructus produced in different regions should be distinguished and differently applied based on their main effective components corresponding to different diseases, which can lead to the best clinical use.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25911817

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  3 in total

Review 1.  A Comprehensive Review of the Main Lignan Components of Schisandra chinensis (North Wu Wei Zi) and Schisandra sphenanthera (South Wu Wei Zi) and the Lignan-Induced Drug-Drug Interactions Based on the Inhibition of Cytochrome P450 and P-Glycoprotein Activities.

Authors:  Feng Zhang; Jianxiu Zhai; Nan Weng; Jie Gao; Jun Yin; Wansheng Chen
Journal:  Front Pharmacol       Date:  2022-03-11       Impact factor: 5.810

2.  Pharmacokinetics and Main Metabolites of Anwulignan in Mice.

Authors:  Cong Chen; Yanbo Feng; Han Li; Hao Lin; Shu Jing; He Li; Chunmei Wang; Jianguang Chen; Jinghui Sun
Journal:  Front Pharmacol       Date:  2022-07-05       Impact factor: 5.988

3.  Identification of volatile active components in Acori Tatarinowii Rhizome essential oil from different regions in China by C6 glioma cells.

Authors:  Lu Yan; Zhanzhan Liu; Li Xu; Yiyun Qian; Pingping Song; Min Wei
Journal:  BMC Complement Med Ther       Date:  2020-08-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.